Title : A patient with classic biphasic pulmonary blastoma harboring CD74-ROS1 fusion responds to crizotinib.

Pub. Date : 2018

PMID : 29343973






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A patient with classic biphasic pulmonary blastoma harboring CD74-ROS1 fusion responds to crizotinib. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
2 It has been reported that ROS1 rearranged lung adenocarcinoma and squamous cell carcinoma are sensitive to crizotinib, an ALK/MET/ ROS1 multitargeted tyrosine kinase inhibitor. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
3 It has been reported that ROS1 rearranged lung adenocarcinoma and squamous cell carcinoma are sensitive to crizotinib, an ALK/MET/ ROS1 multitargeted tyrosine kinase inhibitor. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
4 We report the first clinical evidence of efficacy shown by crizotinib for targeting CD74-ROS1 fusion in CBPB. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens